scholarly article | Q13442814 |
P50 | author | Jørgen Skov Jensen | Q37376597 |
P2093 | author name string | Kirsten Salado-Rasmussen | |
P2860 | cites work | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic | Q21133562 |
Association between Mycoplasma genitalium and acute endometritis | Q28206155 | ||
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women' | Q33810064 | ||
Sequence-based typing of Mycoplasma genitalium reveals sexual transmission | Q34719702 | ||
Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene | Q34747682 | ||
Mycoplasma genitalium: from Chrysalis to multicolored butterfly | Q35090137 | ||
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease | Q35530456 | ||
Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis | Q35531416 | ||
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection | Q35572958 | ||
Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases | Q35608986 | ||
Azithromycin failure in Mycoplasma genitalium urethritis | Q35792616 | ||
Mycoplasma genitalium presence, resistance and epidemiology in Greenland | Q36159575 | ||
Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic | Q36240112 | ||
Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial | Q36656274 | ||
Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium | Q36971250 | ||
Mycoplasma genitalium: prevalence and behavioural risk factors in the general population | Q37136511 | ||
High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. | Q37579937 | ||
Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene | Q37848501 | ||
Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service | Q37849026 | ||
Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study | Q37852187 | ||
The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy | Q37853910 | ||
Mycoplasma genitalium in asymptomatic patients: implications for screening | Q37854668 | ||
Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. | Q37859666 | ||
Serological investigation of Mycoplasma genitalium in infertile women | Q37873556 | ||
Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women | Q40084684 | ||
A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. | Q42170059 | ||
Risk of HIV or second syphilis infection in Danish men with newly acquired syphilis in the period 2000-2010. | Q42281415 | ||
Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance | Q43722862 | ||
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance | Q46260038 | ||
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study | Q46340504 | ||
Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial | Q46954398 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycoplasma genitalium | Q1930909 |
P304 | page(s) | 24-30 | |
P577 | publication date | 2014-04-11 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey | |
P478 | volume | 59 |
Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
Q37836494 | 2016 European guideline on the management of non-gonococcal urethritis |
Q36933110 | A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens. |
Q37280597 | A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples. |
Q37838437 | Advances in the Understanding and Treatment of Male Urethritis |
Q28554374 | Antimicrobial Susceptibility Patterns of Recent Cuban Mycoplasma genitalium Isolates Determined by a Modified Cell-Culture-Based Method |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q35934198 | Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design |
Q99241152 | Azithromycin combined with doxycycline in non-gonococcal urethritis |
Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
Q37382490 | Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment |
Q56888473 | Clinical and sexual risk correlates of in urban pregnant and non-pregnant young women: cross-sectional outcomes using the baseline data from the Women's BioHealth Study |
Q43087983 | Diagnostic and resistance testing for Mycoplasma genitalium: what will it take? |
Q26744660 | Drug Resistance Mechanisms in Bacteria Causing Sexually Transmitted Diseases and Associated with Vaginosis |
Q38646438 | Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections |
Q35962785 | Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea |
Q42319628 | Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens |
Q37836610 | Evaluation of the Bio-Rad Dx CT/NG/MG® assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urine |
Q90235696 | Four-color multiplex real-time PCR assay prototype targeting azithromycin resistance mutations in Mycoplasma genitalium |
Q40099689 | French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays. |
Q37835821 | Gardnerella vaginalis and Mollicute detection in rectal swabs from men who have sex with men. |
Q40917407 | High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. |
Q89775903 | High prevalence of vaginal and rectal Mycoplasma genitalium macrolide resistance among female STD clinic patients in Seattle, Washington |
Q41521589 | Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. |
Q52659745 | In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens. |
Q93157101 | Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis |
Q37839814 | Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands |
Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
Q48537471 | Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. |
Q41583528 | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens |
Q64999477 | Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017. |
Q59799969 | Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q55234408 | Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. |
Q37218590 | Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States |
Q58699936 | Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance |
Q49711518 | Mycoplasma genitalium infection in Kenyan and US women |
Q27021073 | Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
Q40071934 | Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment |
Q37833830 | Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis |
Q40573620 | Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi'an, China |
Q40062218 | Prevalence and significance of Mycoplasma genitalium in women living with HIV in Denmark |
Q53704311 | Prevalence of Mycoplasma genitalium and Azithromycin-Resistant Infections Among Remnant Clinical Specimens, Los Angeles. |
Q53691269 | Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study. |
Q33562762 | Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia |
Q97075329 | Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis |
Q38928353 | Resistance to Macrolide Antibiotics in Public Health Pathogens |
Q92251336 | Resolution of Symptoms and Resumption of Sex After Diagnosis of Nongonococcal Urethritis Among Men Who Have Sex With Men |
Q57457111 | STI with Mycoplasma genitalium-more common than Chlamydia trachomatis in patients attending youth clinics in Sweden |
Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
Q95792145 | The Prevalence of Mycoplasma genitalium and Association With Human Immunodeficiency Virus Infection in Symptomatic Patients, Johannesburg, South Africa, 2007-2014 |
Q41046965 | Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women |
Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
Q64098896 | Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains |
Q91944412 | Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium |
Search more.